Zurich Insurance Group AG 2Q 2016 -- Forecast

FRANKFURT--The following is a summary of analysts' forecasts for Zurich Insurance Group AG (ZURN.VX) second-quarter results, based on a poll of six analysts conducted by Dow Jones Newswires (figures in million dollars, dividend and target price in Swiss francs, according to IFRS). Earnings figures are scheduled to be released August 11.

=== 
                                         Shareholders' 
                   Business  Net attrib.        equity 
2nd Quarter    oper. profit       income            HY 
AVERAGE                 825          673        30,403 
Prev. Year              943          840        31,883 
+/- in %                -13          -20          -4.6 
 
MEDIAN                  836          643        30,136 
Maximum                 911          775        32,144 
Minimum                 726          605        28,930 
Amount                    6            5             3 
 
Baader-Helvea           781          605            -- 
Barclays                856          711            -- 
Commerzbank             726          629        28,930 
Kepler Cheuvreux        911          775        32,144 
Morgan Stanley          815          643        30,136 
UBS                     861           --            -- 
 
 
            Target price  Rating                 DPS 2016 
AVERAGE           252.60  positive 2    AVERAGE     17.00 
Prev. Quarter     228.50  neutral  4    Prev. Year  17.00 
+/- in %             +11  negative 0    +/- in %       -- 
 
MEDIAN            255.00                MEDIAN         -- 
Maximum           278.00                Maximum        -- 
Minimum           229.00                Minimum        -- 
Amount                 5                Amount          3 
 
Baader-Helvea     271.00  Buy                       17.00 
Barclays          278.00  Overweight                17.00 
Berenberg         255.00  Hold                      17.00 
Commerzbank       230.00  Hold                         -- 
Morgan Stanley        --  Equalweight                  -- 
UBS               229.00  Neutral                      -- 
===

Year-earlier figures are as reported by the company.